Stock Scorecard
Stock Summary for DBV Technologies (DBVT) - $21.61 as of 1/30/2026 9:08:32 PM EST
Total Score
6 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DBVT
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DBVT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DBVT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DBVT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DBVT (35 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DBVT
Financial Details for DBVT
Company Overview |
|
|---|---|
| Ticker | DBVT |
| Company Name | DBV Technologies |
| Country | USA |
| Description | DBV Technologies SA (DBVT) is an innovative biopharmaceutical company based in Montrouge, France, that is transforming the landscape of food allergy treatment through its state-of-the-art Viaskin™ technology platform. Specializing in non-invasive epicutaneous immunotherapies, DBV focuses primarily on peanut allergies and is advancing multiple clinical trials to address significant unmet needs in allergy management. As a clinical-stage enterprise, the company is committed to enhancing patient quality of life by promoting allergen desensitization, positioning itself as a frontrunner in the biopharmaceutical space dedicated to allergy research and treatment. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 21.61 |
| Price 4 Years Ago | 15.30 |
| Last Day Price Updated | 1/30/2026 9:08:32 PM EST |
| Last Day Volume | 395,619 |
| Average Daily Volume | 589,408 |
| 52-Week High | 26.18 |
| 52-Week Low | 3.81 |
| Last Price to 52 Week Low | 467.19% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 26.68 |
| Sector PE | 188.49 |
| 5-Year Average PE | -13.30 |
| Free Cash Flow Ratio | 14.41 |
| Industry Free Cash Flow Ratio | 12.86 |
| Sector Free Cash Flow Ratio | 30.14 |
| Current Ratio Most Recent Quarter | 1.80 |
| Total Cash Per Share | 1.50 |
| Book Value Per Share Most Recent Quarter | 0.39 |
| Price to Book Ratio | 23.73 |
| Industry Price to Book Ratio | 64.54 |
| Sector Price to Book Ratio | 57.14 |
| Price to Sales Ratio Twelve Trailing Months | 227.01 |
| Industry Price to Sales Ratio Twelve Trailing Months | 30.05 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.56 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 54,292,000 |
| Market Capitalization | 1,173,250,120 |
| Institutional Ownership | 13.50% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -56.36% |
| Reported EPS 12 Trailing Months | -5.20 |
| Reported EPS Past Year | -0.78 |
| Reported EPS Prior Year | -2.60 |
| Net Income Twelve Trailing Months | -125,533,399 |
| Net Income Past Year | -113,716,769 |
| Net Income Prior Year | -72,726,000 |
| Quarterly Revenue Growth YOY | 158.80% |
| 5-Year Revenue Growth | -29.46% |
| Operating Margin Twelve Trailing Months | -1,236.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 69,837,000 |
| Total Cash Past Year | 32,456,000 |
| Total Cash Prior Year | 141,367,000 |
| Net Cash Position Most Recent Quarter | 69,660,000 |
| Net Cash Position Past Year | 31,913,000 |
| Long Term Debt Past Year | 543,000 |
| Long Term Debt Prior Year | 510,000 |
| Total Debt Most Recent Quarter | 177,000 |
| Equity to Debt Ratio Past Year | 0.98 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 27,388,000 |
| Total Stockholder Equity Prior Year | 140,186,000 |
| Total Stockholder Equity Most Recent Quarter | 52,854,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -98,544,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.82 |
| Free Cash Flow Past Year | -106,815,000 |
| Free Cash Flow Prior Year | -80,330,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | -0.41 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 11.81 |
System |
|
| Modified | 1/30/2026 9:08:33 PM EST |